United States

3-5 Working Days Free Shipping

0
0
Subtotal: $0.00

No products in the cart.

No products in the cart.

Introduction of New DNA Test – The Genetic Health Predisposition Test

As the revolution in personalised medicine continues, easyDNA Limited has launched its Genetic Health Predisposition Test which provides information about a person’s levels of risk for developing 25 known diseases and conditions.

California, United States – June 20, 2010 — easyDNA, an international DNA paternity testing company, announced the launch of its latest DNA test – the Genetic Health Predisposition DNA Test.

The Genetic Health Predisposition Test analyses a person’s level of risk for developing 25 medical diseases and conditions, including heart conditions, common cancers, auto-immune diseases such as rheumatoid arthritis and lupus, as well as level of risk of developing conditions common to western society such as diabetes and obesity.

The genetic health predisposition test offered by easyDNA is based exclusively on SNP association studies that have been backed by solid scientific research, in order to guarantee the reliability of the test results.

Once the test is concluded, each client will be provided with a detailed report containing an individalised profile of the level of genetic risk he or she has for developing each one of these medical conditions. According to an easyDNA spokesperson, “A lot of time and energy have been invested in ensuring that the results are presented in such a way that they are both detailed, but at the same presented in a format that is clear and easy to understand, so as to make it accessible to the general public.”

The Science Behind the Health DNA Test

The science of this test is based on the study of Specific Nucleotide Polymorphisms, commonly known as SNP’s. An SNP is a small genetic change, or variation, that can occur within a person’s DNA sequence. Recent scientific research has linked the presence of particular SNPs in a person’s DNA profile with the onset of particular diseases and conditions. On this issue the company has stated that “The genetic health predisposition test offered by our company is based exclusively on SNP association studies that have been backed by solid scientific research, in order to guarantee the reliability of the test results’.

This type of health DNA test will be of benefit to anyone who takes his or health seriously. Knowing you are at risk of developing a particular condition will empower you to implement the lifestyle changes necessary in order to prevent its onset. This test covers the most common conditions found in modern western society, such as obesity, diabetes and heart disease. Having a family history of one of these conditions will also increase the likelihood that you are at risk for developing the same condition.

Through the genetic health predisposition DNA test you will be able to know whether you have inherited a genetic tendency toward developing particular conditions that run in your family. Knowing you are at high risk will enable you to make those changes necessary in order to help you live a longer and healthier life.

Sales and Marketing director Andrew Hughes stated, “We have seen a definite increase in interest in this type of preventative test. Whereas previously, DNA testing in the medical field has been oriented toward the diagnosis of specific conditions, this type of health DNA test is aimed at helping the general public increase their awareness of their predisposition toward developing a wide range of common conditions, and so enable them to actively implement measures towards preventing its onset.”

The company confirmed that taking the Genetic Health Predisposition Test involves a fairly simple and straightforward procedure. The DNA sample is collected through a pinprick of blood which is then sent back to the laboratory for analysis. Results are available quickly, usually within a few weeks. The test can now be ordered online through one of easyDNA’s many websites depending where you are in the world.

PRWeb release : http://www.prweb.com/releases/2010/06/prweb4145504.htm

Share:

Facebook
Twitter
Pinterest
LinkedIn

We use cookies to improve your browsing experience. By clicking “Accept Cookies”, you agree to the storing of cookies on your device to enhance site navigation & analyze site usage. Click to view our Privacy Policy.